Statin use and risk of cutaneous melanoma: a nationwide nested case-control study

Br J Dermatol. 2023 May 24;188(6):805-807. doi: 10.1093/bjd/ljad057.
No abstract available

MeSH terms

  • Case-Control Studies
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects
  • Melanoma* / chemically induced
  • Melanoma* / epidemiology
  • Melanoma* / prevention & control
  • Melanoma, Cutaneous Malignant
  • Skin Neoplasms* / chemically induced
  • Skin Neoplasms* / epidemiology
  • Skin Neoplasms* / prevention & control

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors